Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling
Clinical trial NCT01868022 · COMPLETED
Trial details
- NCT number
- NCT01868022
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-09
- Primary completion
- 2017-10-24
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.